InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Feder Julie B, Chief Financial Officer. Director active across 1 company, notably Aura Biosciences, Inc.. Cumulatively, 9 filings have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €137k. Activity tracked since 28 October 2021. The latest transaction was filed on 18 October 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Feder Julie B is Directeur Financier at Aura Biosciences, Inc. (XNAS). There are 9 filings in total, and across the 9 sampled filings between 2021-10-29 and 2024-10-21, sell transactions total 137342 EUR and the most frequent transaction nature is Cession.